[1] 王云,王明悦,夏杨,等. 银屑病的生物制剂治疗进展 [J]. 中国医学前沿杂志(电子版), 2021, 13 (12): 13-18.
[2] Rønholt K, Iversen L. Old and New Biological Therapies for Psoriasis. Int J Mol Sci. 2017 Nov 1;18(11):2297.
[3] 中华医学会皮肤性病学分会银屑病专业委员会.中国银屑病诊疗指南（2023版）[J].华皮肤科杂志,2023,56(7):573-625.
[4] Petra Staubach, et al. AAD 2024. P52654.
[5] Pinter A, et al. J Eur Acad Dermatol Venereol. 2022;36(11):2087-2100. Appendix.
[6] Pinter A, et al. Dermatol Ther (Heidelb). 2023 Dec 19.
[7] Blauvelt A, Lebwohl MG, Mabuchi T, et al. Long-term efficacy and safety of ixekizumab: A 5-year analysis of the UNCOVER-3 randomized controlled trial. J Am Acad Dermatol. 2021 Aug;85(2):360-368.
[8] Christopher E. M Griffiths, et al. AAD 2022.32236.
[9] 中华医学会皮肤性病学分会，等. 中国银屑病生物制剂治疗指南（2021）. 中华皮肤科杂志，2021，54(12):1033-1047.
[10] 依奇珠单抗注射液说明书.
